Hiroki Eguchi
6 Papers
Hiroki Eguchi is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has co-authored 1 publications.
Chat about Author
Papers
MO23-6 A single-center experience of comprehensive genomic profiling of hepatobiliary and pancreatic cancers
Hiroki Eguchi,Hiroshi Imaoka,Kanae Inoue,Tomonao Taira,K. Okumura,Taro Shibuki,Kazuo Watanabe,Mitsuhito Sasaki,Shuichi Mitsunaga,Masafumi Ikeda +9 more
TL;DR: In this paper , the authors investigated the success rate of CGP and the transition rate to matched targeted therapy based on CGP for hepatobiliary and pancreatic cancers for liver cancer.
P17-5 Early onset of anorexia-cachexia related worsening of cachexia symptoms during chemotherapy for pancreatic cancer
Shuichi Mitsunaga,Kanae Inoue,Tomonao Taira,Hiroki Eguchi,K. Okumura,Taro Shibuki,Kazuo Watanabe,Mitsuhito Sasaki,Hiroshi Imaoka,Masafumi Ikeda +9 more
TL;DR: In this article , a framework of anorexia-cachexia includes incidence and timing, and its impact on weight loss, adverse event and survival during first-line chemotherapy for advanced pancreatic cancer.
Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis in a Patient with Low Bone Mineral Density Due to Fanconi-Bickel Syndrome.
Makoto Tanaka,Mayuko Nakanishi,Hajime Miyazaki,Ryuichi Morita,Hiroki Eguchi,Yoshiya Takeda,Masanobu Katayama,Motoo Tanaka,Masamichi Bamba,Tadashi Shigematsu +9 more
TL;DR: In this paper, the successful induction of remission in an ulcerative colitis case with a low bone mineral density due to Fanconi-Bickel syndrome using granulocyte and monocyte adsorptive apheresis (GMA) was reported.
Benefits of measuring urinary protein/creatinine ratio in lenvatinib treatment for unresectable hepatocellular carcinoma.
Koki Morishita,Hidetaka Suzuki,J. Tauchi,Misaki Takeno,Shota Yamaguchi,Kanae Inoue,Tomonao Taira,Hiroki Eguchi,K. Okumura,Taro Shibuki,Tomoyuki Satake,Kazuo Watanabe,Hiroshi Imaoka,Mitsuhito Sasaki,Shuichi Mitsunaga,Toshikatsu Kawasaki,Masafumi Ikeda +16 more
TL;DR: In this paper , the effect of measuring UPCR on the treatment efficacy and safety in unresectable hepatocellular carcinoma (uHCC) patients receiving LEN was investigated.
MO6-5 Tumor microenvironment and clinical efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma
Tomonao Taira,Motohiro Kojima,Shota Yamaguchi,Kanae Inoue,Hiroki Eguchi,Kei Okumura,Taro Shibuki,Tomoyuki Satake,Kazuo Watanabe,Mitsuhito Sasaki,Hiroshi Imaoka,Shuichi Mitsunaga,Genichiro Ishii,Masafumi Ikeda +13 more
TL;DR: This study investigates the association between tumor microenvironment and clinical efficacy of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma patients, examining the preferred first-line systemic therapy's effectiveness in relation to the tumor microenvironment.